世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

イソプリノシンの世界市場インサイト、2029年までの予測


Global Isoprinosine Market Insights, Forecast to 2029

2023年に2億4,124万米ドルと推定されるイソプリノシンの世界市場は、2023年から2029年の予測期間中に3.8%のCAGRで成長し、2029年までに3億170万米ドルの修正規模に達すると予測されている。 イソプリノシンの北... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年10月10日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

2023年に2億4,124万米ドルと推定されるイソプリノシンの世界市場は、2023年から2029年の予測期間中に3.8%のCAGRで成長し、2029年までに3億170万米ドルの修正規模に達すると予測されている。
イソプリノシンの北米市場は、2023年から2029年の予測期間中に4.61%のCAGRで、2023年の261万ドルから増加し、2029年には342万ドルに達すると推定される。
イソプリノシンの中国市場は、2023年から2029年の予測期間中に4.54%のCAGRで、2023年に465万ドルから増加し、2029年には607万ドルに達すると推定される。
イソプリノシンのヨーロッパ市場は、2023年から2029年の予測期間中に3.74%のCAGRで、2023年に1億5,275万ドルから増加し、2029年までに1億9,035万ドルに達すると推定される。
イソプリノシンの世界の主要メーカーは、Newport Pharmaceuticals、Gedeon Richter、持田製薬、Sanofi、Andrómaco、Yung Shin、Alfasigma S.p.A.、Polfarmex、Sanferなどである。2022年には、世界の上位5社の売上高シェアは約69%であった。
レポート内容

イソプリノシンの世界市場概要、売上、収益、価格を紹介。2018年~2022年の過去の市場収益/販売データ、2023年の予測、2029年までのCAGR予測による世界市場動向の分析。
イソプリノシンの主要生産者を調査し、主要地域・国の売上高も掲載しています。イソプリノシンの今後の市場可能性のハイライトと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点。米国、カナダ、メキシコ、チリ、中国、日本、韓国、東南アジア、インド、イタリア、フランス、ハンガリー、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートは、2018年から2023年までのデータで、イソプリノシンの売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当てています。世界のイソプリノシン市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争環境を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2018年から2029年までのタイプ別、用途別のセグメントデータ、売上高、収益、価格を分析しています。イソプリノシンの販売、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模の評価と予測。
Newport Pharmaceuticals、Gedeon Richter、持田製薬、サノフィ、Andrómaco、Yung Shin、Alfasigma S.p.A.、Polfarmex、Sanferなど、世界の主要企業の詳細な企業プロフィール。

会社別
ニューポート・ファーマシューティカルズ
ゲデオン・リヒター
持田製薬
サノフィ
アンドロマコ
ユン・シン
アルファシグマ
ポルファルメックス
サンファー
メプロファーム
ノベル・ファーマシューティカル
アフロファーム
コラ・ヘルスケア

タイプ別セグメント
錠剤
シロップ剤

用途別セグメント
病院・クリニック
薬局
その他

地域別セグメント
北米
米国
カナダ
中国
アジア(中国を除く)
日本
韓国
東南アジア
インド
ヨーロッパ
イタリア
ポーランド
フランス
ハンガリー
ロシア
中東、アフリカ、中南米
チリ
メキシコ
中東
アフリカ

各章の概要
第1章:報告書のスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章 イソプリノシンの世界、地域レベル、国レベルでの販売(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、将来の発展見通し、市場空間、生産能力などを紹介する。
第3章:イソプリノシンメーカーの競争環境、価格、売上高、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などを詳しく分析する。
第4章:種類別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのを助ける。
第5章:読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーする、アプリケーション別の様々な市場セグメントの分析を提供します。
第6章 北米(北米):タイプ別、用途別、国別、セグメント別の売上高、収益。
第7章:ヨーロッパ(欧州):タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章:中国:タイプ別、用途別、セグメント別の売上高、収益。
第9章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。
第10章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。
第11章:主要メーカーのプロフィールを提供し、製品の説明と仕様、イソプリノシンの売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本状況を詳しく紹介する。
第12章:産業チェーン、販売チャンネル、主要原材料、流通業者と顧客の分析。
第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第14章:レポートの要点と結論。

ページTOPに戻る


目次

1 STUDY COVERAGE 1
1.1 Isoprinosine Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Isoprinosine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 2
1.2.2 Tablet 3
1.2.3 Syrup 4
1.3 Market by Application 5
1.3.1 Global Isoprinosine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 5
1.3.2 Hospital & Clinic 6
1.3.3 Pharmacy 7
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 9
2 EXECUTIVE SUMMARY 11
2.1 Global Isoprinosine Revenue Estimates and Forecasts 2018-2029 11
2.2 Global Isoprinosine Revenue by Region 12
2.2.1 Global Isoprinosine Revenue by Region: 2018 VS 2022 VS 2029 12
2.2.2 Global Isoprinosine Revenue by Region (2018-2023) 15
2.2.3 Global Isoprinosine Revenue by Region (2024-2029) 15
2.2.4 Global Isoprinosine Revenue Market Share by Region (2018-2029) 15
2.3 Global Isoprinosine Sales Estimates and Forecasts 2018-2029 17
2.4 Global Isoprinosine Sales by Region 17
2.4.1 Global Isoprinosine Sales by Region: 2018 VS 2022 VS 2029 17
2.4.2 Global Isoprinosine Sales by Region (2018-2023) 18
2.4.3 Global Sales Isoprinosine by Region (2024-2029) 18
2.4.4 Global Isoprinosine Sales Market Share by Region (2018-2029) 19
2.5 North America 20
2.6 Europe 21
2.7 China 22
2.8 Asia (excluding China) 23
2.9 Middle East, Africa and Latin America 24
3 COMPETITION BY MANUFACTURERS 26
3.1 Global Isoprinosine Sales by Manufacturers 26
3.1.1 Global Isoprinosine Sales by Manufacturers (2018-2023) 26
3.1.2 Global Isoprinosine Sales Market Share by Manufacturers (2018-2023) 27
3.1.3 Global Top Largest Manufacturers of Isoprinosine in 2022 27
3.2 Global Isoprinosine Revenue by Manufacturers 28
3.2.1 Global Isoprinosine Revenue by Manufacturers (2018-2023) 28
3.2.2 Global Isoprinosine Revenue Market Share by Manufacturers (2018-2023) 29
3.2.3 Global Top Companies by Isoprinosine Revenue in 2022 30
3.3 Global Key Players of Isoprinosine, Industry Ranking, 2021 VS 2022 30
3.4 Global Isoprinosine Sales Price by Manufacturers (2018-2023) 31
3.5 Analysis of Competitive Landscape 32
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 32
3.5.2 Global Isoprinosine Market by Company Type (Tier 1, Tier 2, and Tier 3) 32
3.6 Global Key Manufacturers of Isoprinosine, Manufacturing Base Distribution and Headquarters 33
3.7 Global Key Manufacturers of Isoprinosine, Product Offered 34
3.8 Global Key Manufacturers of Isoprinosine, Date of Enter into This Industry 34
3.9 ***Mergers & Acquisitions, Expansion Plans 35
4 MARKET SIZE BY TYPE 36
4.1 Global Isoprinosine Sales by Type 36
4.1.1 Global Isoprinosine Historical Sales by Type (2018-2023) 36
4.1.2 Global Isoprinosine Forecasted Sales by Type (2024-2029) 36
4.1.3 Global Isoprinosine Sales Market Share by Type (2018-2029) 36
4.2 Global Isoprinosine Revenue by Type 37
4.2.1 Global Isoprinosine Historical Revenue by Type (2018-2023) 37
4.2.2 Global Isoprinosine Forecasted Revenue by Type (2024-2029) 38
4.2.3 Global Isoprinosine Revenue Market Share by Type (2018-2029) 38
4.3 Global Isoprinosine Price by Type 39
4.3.1 Global Isoprinosine Price by Type (2018-2023) 39
4.3.2 Global Isoprinosine Price Forecast by Type (2024-2029) 39
5 MARKET SIZE BY APPLICATION 40
5.1 Global Isoprinosine Sales by Application 40
5.1.1 Global Isoprinosine Historical Sales by Application (2018-2023) 40
5.1.2 Global Isoprinosine Forecasted Sales by Application (2024-2029) 40
5.1.3 Global Isoprinosine Sales Market Share by Application (2018-2029) 40
5.2 Global Isoprinosine Revenue by Application 41
5.2.1 Global Isoprinosine Historical Revenue by Application (2018-2023) 41
5.2.2 Global Isoprinosine Forecasted Revenue by Application (2024-2029) 42
5.2.3 Global Isoprinosine Revenue Market Share by Application (2018-2029) 42
5.3 Global Isoprinosine Price by Application 43
5.3.1 Global Isoprinosine Price by Application (2018-2023) 43
5.3.2 Global Isoprinosine Price Forecast by Application (2024-2029) 43
6 NORTH AMERICA 44
6.1 North America Isoprinosine Market Size by Type 44
6.1.1 North America Isoprinosine Sales by Type (2018-2029) 44
6.1.2 North America Isoprinosine Revenue by Type (2018-2029) 44
6.2 North America Isoprinosine Market Size by Application 45
6.2.1 North America Isoprinosine Sales by Application (2018-2029) 45
6.2.2 North America Isoprinosine Revenue by Application (2018-2029) 46
6.3 North America Isoprinosine Market Size by Country 47
6.3.1 North America Isoprinosine Revenue by Country: 2018 VS 2022 VS 2029 47
6.3.2 North America Isoprinosine Revenue by Country (2018-2029) 47
6.3.3 North America Isoprinosine Sales by Country (2018-2029) 47
6.3.4 Canada 48
7 EUROPE 49
7.1 Europe Isoprinosine Market Size by Type 49
7.1.1 Europe Isoprinosine Sales by Type (2018-2029) 49
7.1.2 Europe Isoprinosine Revenue by Type (2018-2029) 50
7.2 Europe Isoprinosine Market Size by Application 51
7.2.1 Europe Isoprinosine Sales by Application (2018-2029) 51
7.2.2 Europe Isoprinosine Revenue by Application (2018-2029) 52
7.3 Europe Isoprinosine Market Size by Country 53
7.3.1 Europe Isoprinosine Revenue by Country: 2018 VS 2022 VS 2029 53
7.3.2 Europe Isoprinosine Revenue by Country (2018-2029) 53
7.3.3 Europe Isoprinosine Sales by Country (2018-2029) 54
7.3.4 Italy 56
7.3.5 Poland 56
7.3.6 France 57
7.3.7 Hungary 57
7.3.8 Russia 58
8 CHINA 59
8.1 China Isoprinosine Market Size by Type 59
8.1.1 China Isoprinosine Sales by Type (2018-2029) 59
8.1.2 China Isoprinosine Revenue by Type (2018-2029) 60
8.2 China Isoprinosine Market Size by Application 61
8.2.1 China Isoprinosine Sales by Application (2018-2029) 61
8.2.2 China Isoprinosine Revenue by Application (2018-2029) 62
9 ASIA (EXCLUDING CHINA) 63
9.1 Asia Isoprinosine Market Size by Type 63
9.1.1 Asia Isoprinosine Sales by Type (2018-2029) 63
9.1.2 Asia Isoprinosine Revenue by Type (2018-2029) 64
9.2 Asia Isoprinosine Market Size by Application 65
9.2.1 Asia Isoprinosine Sales by Application (2018-2029) 65
9.2.2 Asia Isoprinosine Revenue by Application (2018-2029) 66
9.3 Asia Isoprinosine Market Size by Region 67
9.3.1 Asia Isoprinosine Revenue by Region: 2018 VS 2022 VS 2029 67
9.3.2 Asia Isoprinosine Revenue by Region (2018-2029) 67
9.3.3 Asia Isoprinosine Sales by Region (2018-2029) 68
9.3.4 Japan 69
9.3.5 South Korea 70
9.3.6 Southeast Asia 70
9.3.7 India 71
10 MIDDLE EAST, AFRICA AND LATIN AMERICA 72
10.1 Middle East, Africa and Latin America Isoprinosine Market Size by Type 72
10.1.1 Middle East, Africa and Latin America Isoprinosine Sales by Type (2018-2029) 72
10.1.2 Middle East, Africa and Latin America Isoprinosine Revenue by Type (2018-2029) 73
10.2 Middle East, Africa and Latin America Isoprinosine Market Size by Application 74
10.2.1 Middle East, Africa and Latin America Isoprinosine Sales by Application (2018-2029) 74
10.2.2 Middle East, Africa and Latin America Isoprinosine Revenue by Application (2018-2029) 75
10.3 Middle East, Africa and Latin America Isoprinosine Market Size by Country 77
10.3.1 Middle East, Africa and Latin America Isoprinosine Revenue by Country: 2018 VS 2022 VS 2029 77
10.3.2 Middle East, Africa and Latin America Isoprinosine Revenue by Country (2018-2029) 77
10.3.3 Middle East, Africa and Latin America Isoprinosine Sales by Country (2018-2029) 78
10.3.4 Chile 80
10.3.5 Mexico 80
10.3.6 Middle East 81
10.3.7 Africa 81
11 CORPORATE PROFILE 82
11.1 Newport Pharmaceuticals 82
11.1.1 Newport Pharmaceuticals Company Information 82
11.1.2 Newport Pharmaceuticals Overview 82
11.1.3 Newport Pharmaceuticals Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 83
11.1.4 Newport Pharmaceuticals Isoprinosine Product Introduction 83
11.1.5 Newport Pharmaceuticals Recent Developments 84
11.2 Gedeon Richter 85
11.2.1 Gedeon Richter Company Information 85
11.2.2 Gedeon Richter Overview 85
11.2.3 Gedeon Richter Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 86
11.2.4 Gedeon Richter Isoprinosine Product Introduction 86
11.2.5 Gedeon Richter Recent Developments 87
11.3 Mochida 88
11.3.1 Mochida Company Information 88
11.3.2 Mochida Overview 89
11.3.3 Mochida Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 90
11.3.4 Mochida Isoprinosine Product Introduction 90
11.4 Sanofi 91
11.4.1 Sanofi Company Information 91
11.4.2 Sanofi Overview 91
11.4.3 Sanofi Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 92
11.4.4 Sanofi Isoprinosine Product Introduction 92
11.4.5 Sanofi Recent Developments 92
11.5 Andrómaco 93
11.5.1 Andrómaco Company Information 93
11.5.2 Andrómaco Overview 93
11.5.3 Andrómaco Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 94
11.5.4 Andrómaco Isoprinosine Product Introduction 94
11.6 Yung Shin 95
11.6.1 Yung Shin Company Information 95
11.6.2 Yung Shin Overview 95
11.6.3 Yung Shin Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 96
11.6.4 Yung Shin Isoprinosine Product Introduction 96
11.7 Alfasigma S.p.A. 97
11.7.1 Alfasigma S.p.A. Company Information 97
11.7.2 Alfasigma S.p.A. Overview 97
11.7.3 Alfasigma S.p.A. Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 98
11.7.4 Alfasigma S.p.A. Isoprinosine Product Introduction 98
11.8 Polfarmex 99
11.8.1 Polfarmex Company Information 99
11.8.2 Polfarmex Overview 100
11.8.3 Polfarmex Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 100
11.8.4 Polfarmex Isoprinosine Product Introduction 101
11.9 Sanfer 102
11.9.1 Sanfer Company Information 102
11.9.2 Sanfer Overview 103
11.9.3 Sanfer Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 104
11.9.4 Sanfer Isoprinosine Product Introduction 104
11.10 Meprofarm 105
11.10.1 Meprofarm Company Information 105
11.10.2 Meprofarm Overview 106
11.10.3 Meprofarm Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 106
11.10.4 Meprofarm Isoprinosine Product Introduction 106
11.11 Novell Pharmaceutical 107
11.11.1 Novell Pharmaceutical Company Information 107
11.11.2 Novell Pharmaceutical Overview 108
11.11.3 Novell Pharmaceutical Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 109
11.11.4 Novell Pharmaceutical Isoprinosine Product Introduction 109
11.12 Aflofarm 109
11.12.1 Aflofarm Company Information 109
11.12.2 Aflofarm Overview 110
11.12.3 Aflofarm Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 110
11.12.4 Aflofarm Isoprinosine Product Introduction 111
11.13 KoRa Healthcare 112
11.13.1 KoRa Healthcare Company Information 112
11.13.2 KoRa Healthcare Overview 113
11.13.3 KoRa Healthcare Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 114
11.13.4 KoRa Healthcare Isoprinosine Product Introduction 114
11.13.5 KoRa Healthcare Recent Developments 115
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 116
12.1 Isoprinosine Industry Chain Analysis 116
12.2 Isoprinosine Key Raw Materials 117
12.2.1 Key Raw Materials 117
12.2.2 Raw Materials Key Suppliers 117
12.3 Isoprinosine Production Mode & Process 119
12.4 Isoprinosine Sales and Marketing 120
12.4.1 Isoprinosine Sales Channels 120
12.4.2 Isoprinosine Distributors 121
12.5 Isoprinosine Customers 123
13 ISOPRINOSINE MARKET DYNAMICS 125
13.1.1 Isoprinosine Industry Trends 125
13.1.2 Isoprinosine Market Drivers 126
13.1.3 Isoprinosine Market Challenges 127
13.1.4 Isoprinosine Market Restraints 128
14 KEY FINDINGS IN THE GLOBAL ISOPRINOSINE STUDY 129
15 APPENDIX 131
15.1 Research Methodology 131
15.1.1 Methodology/Research Approach 131
15.1.2 Data Source 134
15.2 Author Details 137
15.3 Disclaimer 139



 

ページTOPに戻る


 

Summary

The global market for Isoprinosine estimated at US$ 241.24 million in the year 2023, is projected to reach a revised size of US$ 301.7 million by 2029, growing at a CAGR of 3.8% during the forecast period 2023-2029.
The North America market for Isoprinosine is estimated to increase from $ 2.61 million in 2023 to reach $ 3.42 million by 2029, at a CAGR of 4.61% during the forecast period of 2023 through 2029.
The China market for Isoprinosine is estimated to increase from $ 4.65 million in 2023 to reach $ 6.07 million by 2029, at a CAGR of 4.54% during the forecast period of 2023 through 2029.
The Europe market for Isoprinosine is estimated to increase from $ 152.75 million in 2023 to reach $ 190.35 million by 2029, at a CAGR of 3.74% during the forecast period of 2023 through 2029.
The global key manufacturers of Isoprinosine include Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi, Andrómaco, Yung Shin, Alfasigma S.p.A., Polfarmex, and Sanfer, etc. In 2022, the global top five players had a share approximately 69% in terms of revenue.
Report Includes

This report presents an overview of global market for Isoprinosine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Isoprinosine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Isoprinosine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Chile, China, Japan, South Korea, Southeast Asia, India, Italy, the France, Hungary, Middle East, Africa, and Other Countries.

This report focuses on the Isoprinosine sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Isoprinosine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Isoprinosine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi, Andrómaco, Yung Shin, Alfasigma S.p.A., Polfarmex, and Sanfer, etc.

By Company
Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi
Andrómaco
Yung Shin
Alfasigma SpA
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm
KoRa Healthcare

Segment by Type
Tablet
Syrup

Segment by Application
Hospital & Clinic
Pharmacy
Other

Segment by Region
North America
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
Southeast Asia
India
Europe
Italy
Poland
France
Hungary
Russia
Middle East, Africa, Latin America
Chile
Mexico
Middle East
Africa

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Isoprinosine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Isoprinosine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Isoprinosine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 STUDY COVERAGE 1
1.1 Isoprinosine Product Introduction 1
1.2 Market by Type 2
1.2.1 Global Isoprinosine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 2
1.2.2 Tablet 3
1.2.3 Syrup 4
1.3 Market by Application 5
1.3.1 Global Isoprinosine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 5
1.3.2 Hospital & Clinic 6
1.3.3 Pharmacy 7
1.4 Assumptions and Limitations 8
1.5 Study Objectives 9
1.6 Years Considered 9
2 EXECUTIVE SUMMARY 11
2.1 Global Isoprinosine Revenue Estimates and Forecasts 2018-2029 11
2.2 Global Isoprinosine Revenue by Region 12
2.2.1 Global Isoprinosine Revenue by Region: 2018 VS 2022 VS 2029 12
2.2.2 Global Isoprinosine Revenue by Region (2018-2023) 15
2.2.3 Global Isoprinosine Revenue by Region (2024-2029) 15
2.2.4 Global Isoprinosine Revenue Market Share by Region (2018-2029) 15
2.3 Global Isoprinosine Sales Estimates and Forecasts 2018-2029 17
2.4 Global Isoprinosine Sales by Region 17
2.4.1 Global Isoprinosine Sales by Region: 2018 VS 2022 VS 2029 17
2.4.2 Global Isoprinosine Sales by Region (2018-2023) 18
2.4.3 Global Sales Isoprinosine by Region (2024-2029) 18
2.4.4 Global Isoprinosine Sales Market Share by Region (2018-2029) 19
2.5 North America 20
2.6 Europe 21
2.7 China 22
2.8 Asia (excluding China) 23
2.9 Middle East, Africa and Latin America 24
3 COMPETITION BY MANUFACTURERS 26
3.1 Global Isoprinosine Sales by Manufacturers 26
3.1.1 Global Isoprinosine Sales by Manufacturers (2018-2023) 26
3.1.2 Global Isoprinosine Sales Market Share by Manufacturers (2018-2023) 27
3.1.3 Global Top Largest Manufacturers of Isoprinosine in 2022 27
3.2 Global Isoprinosine Revenue by Manufacturers 28
3.2.1 Global Isoprinosine Revenue by Manufacturers (2018-2023) 28
3.2.2 Global Isoprinosine Revenue Market Share by Manufacturers (2018-2023) 29
3.2.3 Global Top Companies by Isoprinosine Revenue in 2022 30
3.3 Global Key Players of Isoprinosine, Industry Ranking, 2021 VS 2022 30
3.4 Global Isoprinosine Sales Price by Manufacturers (2018-2023) 31
3.5 Analysis of Competitive Landscape 32
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 32
3.5.2 Global Isoprinosine Market by Company Type (Tier 1, Tier 2, and Tier 3) 32
3.6 Global Key Manufacturers of Isoprinosine, Manufacturing Base Distribution and Headquarters 33
3.7 Global Key Manufacturers of Isoprinosine, Product Offered 34
3.8 Global Key Manufacturers of Isoprinosine, Date of Enter into This Industry 34
3.9 ***Mergers & Acquisitions, Expansion Plans 35
4 MARKET SIZE BY TYPE 36
4.1 Global Isoprinosine Sales by Type 36
4.1.1 Global Isoprinosine Historical Sales by Type (2018-2023) 36
4.1.2 Global Isoprinosine Forecasted Sales by Type (2024-2029) 36
4.1.3 Global Isoprinosine Sales Market Share by Type (2018-2029) 36
4.2 Global Isoprinosine Revenue by Type 37
4.2.1 Global Isoprinosine Historical Revenue by Type (2018-2023) 37
4.2.2 Global Isoprinosine Forecasted Revenue by Type (2024-2029) 38
4.2.3 Global Isoprinosine Revenue Market Share by Type (2018-2029) 38
4.3 Global Isoprinosine Price by Type 39
4.3.1 Global Isoprinosine Price by Type (2018-2023) 39
4.3.2 Global Isoprinosine Price Forecast by Type (2024-2029) 39
5 MARKET SIZE BY APPLICATION 40
5.1 Global Isoprinosine Sales by Application 40
5.1.1 Global Isoprinosine Historical Sales by Application (2018-2023) 40
5.1.2 Global Isoprinosine Forecasted Sales by Application (2024-2029) 40
5.1.3 Global Isoprinosine Sales Market Share by Application (2018-2029) 40
5.2 Global Isoprinosine Revenue by Application 41
5.2.1 Global Isoprinosine Historical Revenue by Application (2018-2023) 41
5.2.2 Global Isoprinosine Forecasted Revenue by Application (2024-2029) 42
5.2.3 Global Isoprinosine Revenue Market Share by Application (2018-2029) 42
5.3 Global Isoprinosine Price by Application 43
5.3.1 Global Isoprinosine Price by Application (2018-2023) 43
5.3.2 Global Isoprinosine Price Forecast by Application (2024-2029) 43
6 NORTH AMERICA 44
6.1 North America Isoprinosine Market Size by Type 44
6.1.1 North America Isoprinosine Sales by Type (2018-2029) 44
6.1.2 North America Isoprinosine Revenue by Type (2018-2029) 44
6.2 North America Isoprinosine Market Size by Application 45
6.2.1 North America Isoprinosine Sales by Application (2018-2029) 45
6.2.2 North America Isoprinosine Revenue by Application (2018-2029) 46
6.3 North America Isoprinosine Market Size by Country 47
6.3.1 North America Isoprinosine Revenue by Country: 2018 VS 2022 VS 2029 47
6.3.2 North America Isoprinosine Revenue by Country (2018-2029) 47
6.3.3 North America Isoprinosine Sales by Country (2018-2029) 47
6.3.4 Canada 48
7 EUROPE 49
7.1 Europe Isoprinosine Market Size by Type 49
7.1.1 Europe Isoprinosine Sales by Type (2018-2029) 49
7.1.2 Europe Isoprinosine Revenue by Type (2018-2029) 50
7.2 Europe Isoprinosine Market Size by Application 51
7.2.1 Europe Isoprinosine Sales by Application (2018-2029) 51
7.2.2 Europe Isoprinosine Revenue by Application (2018-2029) 52
7.3 Europe Isoprinosine Market Size by Country 53
7.3.1 Europe Isoprinosine Revenue by Country: 2018 VS 2022 VS 2029 53
7.3.2 Europe Isoprinosine Revenue by Country (2018-2029) 53
7.3.3 Europe Isoprinosine Sales by Country (2018-2029) 54
7.3.4 Italy 56
7.3.5 Poland 56
7.3.6 France 57
7.3.7 Hungary 57
7.3.8 Russia 58
8 CHINA 59
8.1 China Isoprinosine Market Size by Type 59
8.1.1 China Isoprinosine Sales by Type (2018-2029) 59
8.1.2 China Isoprinosine Revenue by Type (2018-2029) 60
8.2 China Isoprinosine Market Size by Application 61
8.2.1 China Isoprinosine Sales by Application (2018-2029) 61
8.2.2 China Isoprinosine Revenue by Application (2018-2029) 62
9 ASIA (EXCLUDING CHINA) 63
9.1 Asia Isoprinosine Market Size by Type 63
9.1.1 Asia Isoprinosine Sales by Type (2018-2029) 63
9.1.2 Asia Isoprinosine Revenue by Type (2018-2029) 64
9.2 Asia Isoprinosine Market Size by Application 65
9.2.1 Asia Isoprinosine Sales by Application (2018-2029) 65
9.2.2 Asia Isoprinosine Revenue by Application (2018-2029) 66
9.3 Asia Isoprinosine Market Size by Region 67
9.3.1 Asia Isoprinosine Revenue by Region: 2018 VS 2022 VS 2029 67
9.3.2 Asia Isoprinosine Revenue by Region (2018-2029) 67
9.3.3 Asia Isoprinosine Sales by Region (2018-2029) 68
9.3.4 Japan 69
9.3.5 South Korea 70
9.3.6 Southeast Asia 70
9.3.7 India 71
10 MIDDLE EAST, AFRICA AND LATIN AMERICA 72
10.1 Middle East, Africa and Latin America Isoprinosine Market Size by Type 72
10.1.1 Middle East, Africa and Latin America Isoprinosine Sales by Type (2018-2029) 72
10.1.2 Middle East, Africa and Latin America Isoprinosine Revenue by Type (2018-2029) 73
10.2 Middle East, Africa and Latin America Isoprinosine Market Size by Application 74
10.2.1 Middle East, Africa and Latin America Isoprinosine Sales by Application (2018-2029) 74
10.2.2 Middle East, Africa and Latin America Isoprinosine Revenue by Application (2018-2029) 75
10.3 Middle East, Africa and Latin America Isoprinosine Market Size by Country 77
10.3.1 Middle East, Africa and Latin America Isoprinosine Revenue by Country: 2018 VS 2022 VS 2029 77
10.3.2 Middle East, Africa and Latin America Isoprinosine Revenue by Country (2018-2029) 77
10.3.3 Middle East, Africa and Latin America Isoprinosine Sales by Country (2018-2029) 78
10.3.4 Chile 80
10.3.5 Mexico 80
10.3.6 Middle East 81
10.3.7 Africa 81
11 CORPORATE PROFILE 82
11.1 Newport Pharmaceuticals 82
11.1.1 Newport Pharmaceuticals Company Information 82
11.1.2 Newport Pharmaceuticals Overview 82
11.1.3 Newport Pharmaceuticals Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 83
11.1.4 Newport Pharmaceuticals Isoprinosine Product Introduction 83
11.1.5 Newport Pharmaceuticals Recent Developments 84
11.2 Gedeon Richter 85
11.2.1 Gedeon Richter Company Information 85
11.2.2 Gedeon Richter Overview 85
11.2.3 Gedeon Richter Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 86
11.2.4 Gedeon Richter Isoprinosine Product Introduction 86
11.2.5 Gedeon Richter Recent Developments 87
11.3 Mochida 88
11.3.1 Mochida Company Information 88
11.3.2 Mochida Overview 89
11.3.3 Mochida Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 90
11.3.4 Mochida Isoprinosine Product Introduction 90
11.4 Sanofi 91
11.4.1 Sanofi Company Information 91
11.4.2 Sanofi Overview 91
11.4.3 Sanofi Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 92
11.4.4 Sanofi Isoprinosine Product Introduction 92
11.4.5 Sanofi Recent Developments 92
11.5 Andrómaco 93
11.5.1 Andrómaco Company Information 93
11.5.2 Andrómaco Overview 93
11.5.3 Andrómaco Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 94
11.5.4 Andrómaco Isoprinosine Product Introduction 94
11.6 Yung Shin 95
11.6.1 Yung Shin Company Information 95
11.6.2 Yung Shin Overview 95
11.6.3 Yung Shin Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 96
11.6.4 Yung Shin Isoprinosine Product Introduction 96
11.7 Alfasigma S.p.A. 97
11.7.1 Alfasigma S.p.A. Company Information 97
11.7.2 Alfasigma S.p.A. Overview 97
11.7.3 Alfasigma S.p.A. Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 98
11.7.4 Alfasigma S.p.A. Isoprinosine Product Introduction 98
11.8 Polfarmex 99
11.8.1 Polfarmex Company Information 99
11.8.2 Polfarmex Overview 100
11.8.3 Polfarmex Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 100
11.8.4 Polfarmex Isoprinosine Product Introduction 101
11.9 Sanfer 102
11.9.1 Sanfer Company Information 102
11.9.2 Sanfer Overview 103
11.9.3 Sanfer Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 104
11.9.4 Sanfer Isoprinosine Product Introduction 104
11.10 Meprofarm 105
11.10.1 Meprofarm Company Information 105
11.10.2 Meprofarm Overview 106
11.10.3 Meprofarm Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 106
11.10.4 Meprofarm Isoprinosine Product Introduction 106
11.11 Novell Pharmaceutical 107
11.11.1 Novell Pharmaceutical Company Information 107
11.11.2 Novell Pharmaceutical Overview 108
11.11.3 Novell Pharmaceutical Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 109
11.11.4 Novell Pharmaceutical Isoprinosine Product Introduction 109
11.12 Aflofarm 109
11.12.1 Aflofarm Company Information 109
11.12.2 Aflofarm Overview 110
11.12.3 Aflofarm Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 110
11.12.4 Aflofarm Isoprinosine Product Introduction 111
11.13 KoRa Healthcare 112
11.13.1 KoRa Healthcare Company Information 112
11.13.2 KoRa Healthcare Overview 113
11.13.3 KoRa Healthcare Isoprinosine Sales, Price, Revenue and Gross Margin (2018-2023) 114
11.13.4 KoRa Healthcare Isoprinosine Product Introduction 114
11.13.5 KoRa Healthcare Recent Developments 115
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 116
12.1 Isoprinosine Industry Chain Analysis 116
12.2 Isoprinosine Key Raw Materials 117
12.2.1 Key Raw Materials 117
12.2.2 Raw Materials Key Suppliers 117
12.3 Isoprinosine Production Mode & Process 119
12.4 Isoprinosine Sales and Marketing 120
12.4.1 Isoprinosine Sales Channels 120
12.4.2 Isoprinosine Distributors 121
12.5 Isoprinosine Customers 123
13 ISOPRINOSINE MARKET DYNAMICS 125
13.1.1 Isoprinosine Industry Trends 125
13.1.2 Isoprinosine Market Drivers 126
13.1.3 Isoprinosine Market Challenges 127
13.1.4 Isoprinosine Market Restraints 128
14 KEY FINDINGS IN THE GLOBAL ISOPRINOSINE STUDY 129
15 APPENDIX 131
15.1 Research Methodology 131
15.1.1 Methodology/Research Approach 131
15.1.2 Data Source 134
15.2 Author Details 137
15.3 Disclaimer 139



 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/10/04 10:27

147.72 円

163.39 円

196.69 円

ページTOPに戻る